Alvotech (ALVO)
12.44
+0.02
(+0.16%)
USD |
NASDAQ |
Nov 21, 16:00
12.40
-0.04
(-0.32%)
After-Hours: 20:00
Alvotech Enterprise Value: 4.660B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 4.660B |
| November 20, 2024 | 4.654B |
| November 19, 2024 | 4.678B |
| November 18, 2024 | 4.558B |
| November 15, 2024 | 4.446B |
| November 14, 2024 | 4.549B |
| November 13, 2024 | 4.507B |
| November 12, 2024 | 4.576B |
| November 11, 2024 | 4.591B |
| November 08, 2024 | 4.736B |
| November 07, 2024 | 4.727B |
| November 06, 2024 | 4.754B |
| November 05, 2024 | 4.799B |
| November 04, 2024 | 4.805B |
| November 01, 2024 | 4.835B |
| October 31, 2024 | 4.823B |
| October 30, 2024 | 4.760B |
| October 29, 2024 | 4.817B |
| October 28, 2024 | 4.826B |
| October 25, 2024 | 4.853B |
| October 24, 2024 | 4.844B |
| October 23, 2024 | 4.799B |
| October 22, 2024 | 4.648B |
| October 21, 2024 | 4.603B |
| October 18, 2024 | 4.630B |
| Date | Value |
|---|---|
| October 17, 2024 | 4.648B |
| October 16, 2024 | 4.648B |
| October 15, 2024 | 4.678B |
| October 14, 2024 | 4.678B |
| October 11, 2024 | 4.663B |
| October 10, 2024 | 4.784B |
| October 09, 2024 | 4.823B |
| October 08, 2024 | 4.784B |
| October 07, 2024 | 4.693B |
| October 04, 2024 | 4.618B |
| October 03, 2024 | 4.618B |
| October 02, 2024 | 4.618B |
| October 01, 2024 | 4.513B |
| September 30, 2024 | 4.498B |
| September 27, 2024 | 4.633B |
| September 26, 2024 | 4.467B |
| September 25, 2024 | 4.428B |
| September 24, 2024 | 4.413B |
| September 23, 2024 | 4.325B |
| September 20, 2024 | 4.397B |
| September 19, 2024 | 4.416B |
| September 18, 2024 | 4.382B |
| September 17, 2024 | 4.364B |
| September 16, 2024 | 4.325B |
| September 13, 2024 | 4.304B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.806B
Minimum
Jul 15 2022
5.732B
Maximum
Feb 26 2024
3.647B
Average
3.457B
Median
Enterprise Value Benchmarks
| Procaps Group SA | -- |
| Johnson & Johnson | 389.84B |
| Pfizer Inc | 199.35B |
| Rigel Pharmaceuticals Inc | 439.73M |
| NovaBay Pharmaceuticals Inc | 2.745M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -11.39M |
| Revenue (Quarterly) | 102.89M |
| Total Expenses (Quarterly) | 90.16M |
| EPS Diluted (Quarterly) | -0.02 |
| Gross Profit Margin (Quarterly) | 61.31% |
| Profit Margin (Quarterly) | -11.07% |
| Earnings Yield | -14.87% |
| Normalized Earnings Yield | -8.817 |